Back to Search
MICHAEL NEMUNAITIS, MD
MD
Medical Oncology Physician
NPI: 1639117781IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
M2419(TX)35093377(OH)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
MEDICAL COLLEGE OF OHIO
Class of 2001
Research & Publications (5)
Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.
PMID 19287371·Cancer Gene Ther·2009
3-trial
Primary effusion lymphoma diagnosed by pericardiocentesis.
PMID 19169406·Proc (Bayl Univ Med Cent)·2009
8-other
Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.
PMID 18802154·J Clin Oncol·2008
3-trial
Proof concept for clinical justification of network mapping for personalized cancer therapeutics.
PMID 17541424·Cancer Gene Ther·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1639117781
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 25
- Publications
- 5
Are you this provider?
Claim Your Profile